Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PRITORPLUS 80 mg/12,5 mg COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PRITORPLUS 80 mg/12,5 mg COMPRIMIDOS

Approved

STANDARD

PRITORPLUS 80 mg/12,5 mg COMPRIMIDOS

Bayer Ag🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 21, 2021
Approval ID: 3d9989ffb5d9c11e
Company: Bayer Ag
Type: Standard

Approval Details

Approval Id: 3d9989ffb5d9c11e
Drug Cima Aemps Name: PRITORPLUS 80 mg/12,5 mg COMPRIMIDOS
Register Number: 02215007IP3
Holder Company Name: Bayer Ag
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/bayer-ag
Authorization Date: 2021-12-21
Dosage Form: COMPRIMIDO
Dose: 80/12,5 mg/mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Bayer Ag
Company Detail Path: /organization/bayer-ag

Company Information

Pharmaceutical Company Name: BAYER AG
Name En: Bayer AG
Country Name: Germany
City Name: Leverkusen
Address: Leverkusen, North Rhine-Westphalia, Germany
Website: https://www.bayer.com

Active Ingredients

TELMISARTAN

80 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 21, 2021

Approval ID

3d9989ffb5d9c11e

Type

Standard

Back to CIMA-AEMPS Approvals